MUC1 and urinary bladder carcinoma: More concerning from a therapeutic side is that MUC1 proteins were found to play a significant role in bladder cancer cells acquiring resistance to cisplatin, one of the major chemotherapeutic agents used to treat bladder cancer patients [26].